Regenerative medicine: A review;Medicina regenerativa: Uma revisão

Revista Brasileira de Hematologia e Hemoterapia

Volumn 31, Issue SUPPL. 2, 2009, Pages 63-66

  Porcellini, Adolfo ^a  

^a Medicina II   (Italy)

Author keywords

Hematopoietic stem cells; Mesenchimal cells; Regenerative medicine

Indexed keywords

EID: 70350397204     PISSN: 15168484     EISSN: None     Source Type: Journal    
DOI: 10.1590/s1516-84842009000800017     Document Type: Review

References (19)

1. Whitman DH, Berry RL, Green DM. Platelet gel: an autologous alternative to fibrin glue with applications in oral and maxillofacial surgery. J Oral Maxillofac Surg. 1997;55(11):1294-9.
2. Marx RE. Platelet-rich plasma: evidence to support its use. J Oral Maxillofac Surg. 2004;62(4):489-96.
3. Okuda K, Kawase T, Momose M, Murata M, Saito Y, Suzuki H, et al. Platelet-rich plasma contains high levels of platelet-derived growth factor and transforming growth factor-beta and modulates the proliferation of periodontally related cells in vitro. J Periodontol. 2003;74(6):849-57.
4. Graziani F, Cei S, Ducci F, Giuca MR, Donos N, Gabriele M. In vitro effects of different concentration of PRP on primary bone and gingival cell lines. Preliminary results. Minerva Stomatol. 2005;54(1-2):15-22.
5. Saldalamacchia G et al. Platelet gel for the therapy of the ulcers of the diabetic foot. GIDM 2004;24:103-105
6. Roukis TS, Zgonis T, Tiernan B. Autologous platelet-rich plasma for wound and osseous healing: a review of the literature and commercially available products. Adv Ther. 2006;23(2):218-37.
7. Schnabel LV, Mohammed HO, Miller BJ, McDermott WG, Jacobson MS, Santangelo KS, et al. Platelet rich plasma (PRP) enhances anabolic gene expression patterns in flexor digitorum superficialis tendons. J Orthop Res. 2007;25(2):230-40.
8. Prockop DJ. Marrow stromal cells as stem cells for non- hematopoietic tissues. Science. 1997;276(5309):71-4.
9. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, et al. Multilineage potential of adult human mesenchymal stem cells. Science. 1999;284(5411):143-7.
10. Deans RJ, Moseley AB. Mesenchymal stem cells: biology and potential clinical uses. Exp Hematol. 2000;28(8):875-84.
11. Prockop DJ, Gregory CA, Spees JL. One strategy for cell and gene therapy: harnessing the power of adult stem cells to repair tissues. Proc Natl Acad Sci U S A. 2003; 100 Suppl 1:11917-23.
12. Minguell JJ, Erices A, Conget P. Mesenchymal stem cells. Exp Biol Med (Maywood). 2001;226(6):507-20.
13. Koç ON, Lazarus HM. Mesenchymal stem cells: heading into the clinic. Bone Marrow Transplant. 2001;27(3):235-9.
14. Briguori C, Reimers B, Sarais C, Napodano M, Pascotto P, Azzarello G, et al. Direct intramyocardial percutaneous delivery of autologous bone marrow in patients with refractory myocardial angina. Am Heart J. 2006;151(3):674-80.
15. Tse HF, Kwong YL, Chan JK, Lo G, Ho CL, Lau CP. Angiogenesis in ischaemic myocardium by intramyocardial autologous bone marrow mononuclear cell implantation. Lancet. 2003;361(9351):47-9.
16. Tateishi-Yuyama E, Matsubara H, Murohara T, Ikeda U, Shintani S, Masaki H, et al. Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial. Lancet. 2002;360(9331):427-35.
17. Akar AR, Durdu S, Arikbuka M et al. Implantation of autologous bone marrow mononuclear cells for Bürger's disease with retractable limb ischaemia. Bone Marrow Transplantation 2005; 35 supp 2 47.
18. LeBlanc K, Rasmusson O. Treatment of severe acute GvHD with third party haploidentical mesenchymal stem cells. Lancet (2004); 363:128-32.
19. Prockop DJ, Olson SD. Clinical trials with adult stem/progenitor cells for tissue repair: let's not overlook some essential precautions. Blood. 2007;109(8):3147-51.